Name: Corcept Therapeutics Incorporated (CORT) Balance Sheet
Creator: FinSpry

Corcept Therapeutics Incorporated Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Corcept Therapeutics Incorporated (CORT) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	127.67	368.22	66.33	223.54	76.19	275.96	206.76
Short-Term Investments	255.67	232.67	365.34	145.92	364.51	0.00	0.00
Cash & Short-Term Investments	383.33	368.22	431.67	223.54	440.70	275.96	206.76
Accounts Receivable	53.98	55.12	46.86	27.63	27.50	19.93	17.59
Inventory	12.41	7.73	6.10	4.99	4.91	11.98	4.73
Other Current Assets	6.08	13.02	14.62	9.24	5.40	6.03	0.00
Total Current Assets	471.60	458.64	499.25	266.46	478.50	307.36	236.82
Non-Current Assets
Property, Plant & Equipment (Net)	8.01	0.32	1.78	1.52	4.18	4.50	0.66
Long-Term Investments	219.83	57.18	4.95	112.28	36.20	0.00	0.00
Other Non-Current Assets	10.19	14.79	15.99	16.05	21.25	3.45	11.56
Total Non-Current Assets	368.95	162.88	84.18	157.29	93.23	92.97	74.87
Total Assets	840.55	621.52	583.43	423.76	571.73	412.31	311.69
Current Liabilities
Accounts Payable	15.38	83.02	11.98	34.57	10.55	30.81	27.69
Short-Term Debt	0.83	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	38.79	70.49	44.52	14.79	34.69	0.00	0.00
Deferred Revenue	41.58	18.47	11.10	11.17	0.00	0.00	0.00
Other Current Liabilities	2.27	25.46	14.76	12.44	0.20	0.00	0.39
Total Current Liabilities	140.77	104.51	72.49	47.54	47.49	38.84	35.57
Non-Current Liabilities
Long-Term Debt	6.11	0.00	0.00	0.00	0.50	1.90	0.00
Other Non-Current Liabilities	14.08	21.33	9.10	0.41	0.40	0.00	0.00
Total Non-Current Liabilities	20.19	31.64	9.10	0.41	14.60	8.77	0.24
Total Liabilities	160.96	114.81	81.59	47.95	48.39	41.13	35.81
Stockholders' Equity
Common Stock	0.14	0.13	0.13	0.13	0.12	0.00	0.00
Retained Earnings	543.74	403.14	296.39	194.74	82.46	-23.56	-117.74
Accumulated Other Comprehensive Income	-0.22	0.61	-0.87	-0.23	0.42	0.26	-0.07
Treasury Stock	696.17	-635.08	-456.15	-410.41	-75.80	-62.70	-23.66
Additional Paid-in Capital	832.11	738.52	662.34	591.35	516.14	457.06	417.23
Shares Outstanding	105.11	103.41	107.84	105.94	0.00	0.00	0.00
Total Stockholders' Equity	679.59	506.71	501.84	375.81	523.34	371.18	275.88
Total Liabilities & Equity	840.55	621.52	583.43	423.76	571.73	412.31	311.69